Radioactive materials play a crucial role in treating cancer, often used in hospitals to target and destroy harmful cells.

HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in ...

One possible solution that the ORNL researchers are exploring as part of the Smart Packaging for Critical Energy Shipments ...

Every day, cancer patients visit medical facilities for treatments to lessen or alleviate the destructive illness. Treatments ...

Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work ...